nitrates has been researched along with Esophageal Varices in 20 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on low-certainty evidence, beta-blockers, variceal band ligation, sclerotherapy, and beta-blockers plus nitrates may decrease mortality compared to no intervention in people with high-risk oesophageal varices in people with cirrhosis and no previous history of bleeding." | 5.12 | Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed in about one to three years of diagnosis." | 2.72 | Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Fritche, D; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis." | 2.72 | Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Milne, EJ; Pavlov, CS; Roberts, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Walshaw, D; Williams, NR, 2021) |
| "Recent advances in the pharmacologic treatment of portal hypertension have mainly focused on modifying an increased intrahepatic resistance through nitric oxide and/or modulation of vasoactive substances." | 2.61 | Pharmacologic Management of Portal Hypertension. ( Bunchorntavakul, C; Reddy, KR, 2019) |
| "In conclusion, chronic administration of organic nitrates, allowing for a nitrate-free interval each day, to cirrhotic patients reduces portal pressure with a variable, dose-dependent effect on azygos blood flow." | 2.39 | Organic nitrates in portal hypertension. ( Hayes, PC; Jones, AL, 1994) |
| "The prevalence of large esophageal varices was 20%." | 1.30 | Predictors of large esophageal varices in patients with cirrhosis. ( Boyer, TD; Carey, M; Chalasani, N; Imperiale, TF; Ismail, A; Kwo, PY; Madichetty, H; Sood, G; Wilcox, CM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunchorntavakul, C | 1 |
| Reddy, KR | 1 |
| Plaz Torres, MC | 2 |
| Best, LM | 3 |
| Freeman, SC | 3 |
| Roberts, D | 3 |
| Cooper, NJ | 3 |
| Sutton, AJ | 3 |
| Roccarina, D | 2 |
| Benmassaoud, A | 2 |
| Iogna Prat, L | 2 |
| Williams, NR | 3 |
| Csenar, M | 3 |
| Fritche, D | 1 |
| Begum, T | 3 |
| Arunan, S | 3 |
| Tapp, M | 3 |
| Milne, EJ | 3 |
| Pavlov, CS | 3 |
| Davidson, BR | 3 |
| Tsochatzis, E | 3 |
| Gurusamy, KS | 3 |
| Walshaw, D | 1 |
| Mustafa, MZ | 1 |
| Stanley, A | 1 |
| Augustin, S | 1 |
| González, A | 1 |
| Badia, L | 1 |
| Millán, L | 1 |
| Gelabert, A | 1 |
| Romero, A | 1 |
| Segarra, A | 1 |
| Martell, M | 1 |
| Esteban, R | 1 |
| Guardia, J | 1 |
| Genescà, J | 1 |
| Groszmann, RJ | 1 |
| Garcia-Tsao, G | 1 |
| Arkenau, HT | 1 |
| Stichtenoth, DO | 1 |
| Frölich, JC | 1 |
| Manns, MP | 1 |
| Böker, KH | 1 |
| Imperiale, TF | 2 |
| Chalasani, N | 2 |
| Klein, RW | 1 |
| Targownik, LE | 1 |
| Spiegel, BM | 1 |
| Dulai, GS | 1 |
| Karsan, HA | 1 |
| Gralnek, IM | 1 |
| Rockey, DC | 1 |
| Jones, AL | 1 |
| Hayes, PC | 1 |
| El-Newihi, HM | 1 |
| Kanji, VK | 1 |
| Mihas, AA | 1 |
| Lebrec, D | 1 |
| Ismail, A | 1 |
| Sood, G | 1 |
| Carey, M | 1 |
| Wilcox, CM | 1 |
| Madichetty, H | 1 |
| Kwo, PY | 1 |
| Boyer, TD | 1 |
| Sanyal, AJ | 1 |
| Angelico, M | 1 |
| Lionetti, R | 1 |
| Lowe, RC | 1 |
| Grace, ND | 1 |
| Vogt, W | 1 |
| Fleig, WE | 1 |
13 reviews available for nitrates and Esophageal Varices
| Article | Year |
|---|---|
Pharmacologic Management of Portal Hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anticoagulants; Antihypertensi | 2019 |
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-2 Receptor Antagonists; Adult; Bias; Esophageal and Gastric Varices; Gastrointestina | 2021 |
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-Antagonists; Bias; Combined Modality Therapy; Drug Therapy, Combination; Esophageal | 2021 |
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Topics: Adult; Bayes Theorem; Bias; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointesti | 2021 |
Variceal rebleeding: use of drug therapy and endoscopic band ligation.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Gastro | 2014 |
Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference?
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Humans; Nitrates; Secondary | 2002 |
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
Topics: Adrenergic beta-Antagonists; Algorithms; Antihypertensive Agents; Cardiovascular Agents; Esophageal | 2006 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans | 1994 |
Review: pharmacotherapeutic agents in the treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Forecasting; Gastrointestinal Hemorrhag | 1997 |
Long-acting nitrates in portal hypertension: to be or not to be?
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Esophageal and Gastric Varices; Female; Ga | 2001 |
Primary prophylaxis of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Hemorrhage; Humans; Hyperten | 2001 |
[The patient with hematemesis. What to do?].
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Electrocoagulation; Emergencies; Endos | 2002 |
Pharmacological methods for the prevention of first and recurrent bleeding from esophagogastric varices.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Esophageal and Gastric Varices; Gastrointesti | 1988 |
7 other studies available for nitrates and Esophageal Varices
| Article | Year |
|---|---|
Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; | 2012 |
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Topics: Ascites; Data Interpretation, Statistical; Esophageal and Gastric Varices; Hemodynamics; Hepatitis, | 2002 |
Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
Topics: Adrenergic beta-Antagonists; Cost-Benefit Analysis; Decision Trees; Esophageal and Gastric Varices; | 2003 |
The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Blood Pressure Determination; Cost-Benefit Analysis; Endoscopy, Digesti | 2004 |
Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
Topics: Adult; Aged; Esophageal and Gastric Varices; Gastric Mucosa; Humans; Hypertension, Portal; Liver Cir | 1996 |
Predictors of large esophageal varices in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Cohort Studies; Confidence Intervals; Cost-Benefit Analysis; Costs and | 1999 |
Hepatic venous pressure gradient: to measure or not to measure, that is the question.
Topics: Adrenergic beta-Antagonists; Drug Synergism; Esophageal and Gastric Varices; Hemorrhage; Hepatic Vei | 2000 |